Harbin Gloria Pharmaceuticals Co.,Ltd.’s Net Profit Rose 1.5% in First Half of 2023

Harbin Gloria Pharmaceuticals Co.,Ltd. (哈尔滨誉衡药业股份有限公司) (002437.SZ) reported a net profit of 32.3 million yuan in the first half of 2023, up 1.5% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, down 10.4% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 1.9 billion yuan in total liabilities, with a liability-to-asset ratio of 52.3%.